Home/Clinical Trials
RecruitingPhase 3CT-2026-101
Emzaratinib after surgery in early-stage lung cancer
Non-small cell lung cancer · Oncology
Ages 18 years and older740 participantsChicago, IL, London, UK +2 more
RecruitingPhase 3CT-2026-105
Tazulimab-cvra in newly diagnosed multiple myeloma
Multiple myeloma · Oncology
Ages 18 years and older1,120 participantsToronto, Canada, Raleigh, NC +1 more
RecruitingPhase 2CT-2025-102
Bispecific CLV-140 in extensive-stage small cell lung cancer
Small cell lung cancer · Oncology
Ages 18 years and older290 participantsLondon, UK, Sydney, Australia
Active, not recruitingPhase 2CT-2025-106
Orevantinib in VRX-1 positive colorectal cancer
Colorectal cancer · Oncology
Ages 18 years and older170 participantsToronto, Canada, Berlin, Germany +3 more
Active, not recruitingPhase 1CT-2024-103
First-in-human study of CLV-147 in platinum-resistant ovarian cancer
Ovarian cancer · Oncology
Ages 18 years and older70 participantsSeoul, South Korea, Sydney, Australia +1 more
Not yet recruitingPhase 1CT-2026-125
CLV-140 in neuroendocrine tumors
Neuroendocrine tumors · Oncology
Ages 18 years and older30 participantsBerlin, Germany, Seoul, South Korea
CompletedPhase 3CT-2023-104
Berolumab-cvra versus chemotherapy in HER-low breast cancer
Breast cancer · Oncology
Ages 18 years and older2,030 participantsHouston, TX, London, UK +1 more
CompletedPhase 3CT-2023-124
Emzaratinib plus chemotherapy in metastatic lung cancer
Non-small cell lung cancer · Oncology
Ages 18 years and older1,120 participantsToronto, Canada, Raleigh, NC +2 more
Study listings are fictional. Talk with your doctor before joining any clinical trial.